Kaneda K, Yoshioka Y, Makita K, Toyooka H, Amaha K
Department of Anesthesiology and Critical Care Medicine, Tokyo Medical and Dental University, School of Medicine, Japan.
Crit Care Med. 1997 Jun;25(6):1019-29. doi: 10.1097/00003246-199706000-00020.
To investigate the effects of 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (carboxy-PTIO), a nitric oxide scavenger, on the lipopolysaccharide-induced hypotension, hepatocellular dysfunction, and liver damage in endotoxic rabbits.
Experimental, comparative study.
Laboratory of a university hospital.
Eighteen Japanese white rabbits (3.0 to 3.2 kg body weight) anesthetized with ketamine-xylazine were studied.
We randomly divided the rabbits into three groups: saline controls (group 1, n = 5); animals receiving lipopolysaccharide (400 micrograms/kg) alone (group 2, n = 8); and animals receiving lipopolysaccharide plus carboxy-PTIO at a rate of 0.17 mg/kg/min for 3 hrs (group 3, n = 5). Blood gases and mean arterial pressure (MAP) were monitored. In vivo phosphorus-31 magnetic resonance spectra were continuously obtained every 30 mins. In addition, the livers were sampled and underwent fractionation at 7 hrs after lipopolysaccharide administration. The hydrophilic and hydrophobic extracts from the livers were analyzed by in vitro hydrogen-1 and phosphorus-31 magnetic resonance spectroscopy.
After the administration of lipopolysaccharide, the first phase of decrease in MAP within 30 mins was followed by partial recovery within the next 30 mins. In group 2, MAP started to decrease progressively within 180 mins after lipopolysaccharide administration (second phase) and decreased by 33% from the baseline value to 49 +/- 9 mm Hg at 420 mins. In contrast, the infusion of carboxy-PTIO significantly attenuated the second decrease in MAP (68 +/- 10 mm Hg, at 420 mins). In group 2, a slow and progressive decrease in adenosine triphosphate (ATP) and increase in inorganic phosphate concentrations occurred from 120 mins after lipopolysaccharide administration, and continued throughout the observation period. These changes were accompanied by a progressive decrease in intracellular pH. On the other hand, in group 3, there were no significant changes in ATP and inorganic phosphate concentrations compared with the controls from 120 to 360 mins after lipopolysaccharide administration. Moreover, restorations of both arterial and hepatocellular acidosis were observed in group 3. The differences of the degree of liver damage--as determined by the total amount of phospholipid, free fatty acids concentration, and membrane fluidity--were not significant among the three groups. Three of eight rabbits in group 2 died within 7 hrs, but no animal in the other two groups died during the study.
The results of this study indicate that the infusion of carboxy-PTIO: a) prevented the delayed hypotension associated with endotoxic shock in rabbits; b) returned the hepatocellular ATP concentrations nearly to the level of the controls and alleviated hepatocellular acidosis; c) normalized various hydrophilic metabolites, such as lactate and alanine in the liver; and d) did not exacerbate liver injury after the administration of lipopolysaccharide. These findings indicate that carboxy-PTIO, a nitric oxide scavenger, may have a positive vasopressor effect during hypodynamic septic shock without exacerbating liver injury.
研究一氧化氮清除剂2-(4-羧基苯基)-4,4,5,5-四甲基咪唑啉-1-氧基-3-氧化物(羧基-PTIO)对内毒素血症兔脂多糖诱导的低血压、肝细胞功能障碍及肝损伤的影响。
实验性对比研究。
大学医院实验室。
18只体重3.0至3.2千克、用氯胺酮-甲苯噻嗪麻醉的日本白兔。
将兔子随机分为三组:生理盐水对照组(第1组,n = 5);单独接受脂多糖(400微克/千克)的动物(第2组,n = 8);以及接受脂多糖加羧基-PTIO以0.17毫克/千克/分钟的速率持续输注3小时的动物(第3组,n = 5)。监测血气和平均动脉压(MAP)。每30分钟连续获取一次体内磷-31磁共振波谱。此外,在给予脂多糖7小时后采集肝脏样本并进行分级分离。通过体外氢-1和磷-31磁共振波谱分析肝脏的亲水和疏水提取物。
给予脂多糖后,MAP在30分钟内出现第一阶段下降,随后在接下来的30分钟内部分恢复。在第2组中,MAP在给予脂多糖后180分钟内开始逐渐下降(第二阶段),在420分钟时从基线值下降33%,降至49±9毫米汞柱。相比之下,输注羧基-PTIO显著减轻了MAP的第二次下降(420分钟时为68±10毫米汞柱)。在第2组中,从给予脂多糖后120分钟开始,三磷酸腺苷(ATP)缓慢且逐渐下降,无机磷酸盐浓度升高,并在整个观察期持续。这些变化伴随着细胞内pH值的逐渐下降。另一方面,在第3组中,给予脂多糖后120至360分钟期间,与对照组相比,ATP和无机磷酸盐浓度无显著变化。此外,在第3组中观察到动脉和肝细胞酸中毒均得到恢复。三组之间由磷脂总量、游离脂肪酸浓度和膜流动性所确定的肝损伤程度差异不显著。第2组的8只兔子中有3只在7小时内死亡,但其他两组在研究期间无动物死亡。
本研究结果表明,输注羧基-PTIO:a)预防了与兔内毒素休克相关的延迟性低血压;b)使肝细胞ATP浓度几乎恢复到对照组水平并减轻了肝细胞酸中毒;c)使肝脏中各种亲水代谢物(如乳酸和丙氨酸)恢复正常;d)在给予脂多糖后未加重肝损伤。这些发现表明,一氧化氮清除剂羧基-PTIO在低动力性脓毒性休克期间可能具有积极的血管升压作用,且不会加重肝损伤。